ImExHS Limited (ASX:IME)
0.4000
-0.0100 (-2.44%)
Jan 21, 2026, 11:15 AM AEST
ImExHS Revenue
ImExHS had revenue of 13.66M AUD in the half year ending June 30, 2025, with 54.11% growth. This brings the company's revenue in the last twelve months to 26.32M, up 5.67% year-over-year. In the year 2024, ImExHS had annual revenue of 26.54M with 33.44% growth.
Revenue (ttm)
26.32M
Revenue Growth
+5.67%
P/S Ratio
0.82
Revenue / Employee
65.79K
Employees
400
Market Cap
21.62M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.54M | 6.65M | 33.44% |
| Dec 31, 2023 | 19.89M | 2.64M | 15.32% |
| Dec 31, 2022 | 17.24M | 3.82M | 28.45% |
| Dec 31, 2021 | 13.43M | 2.44M | 22.25% |
| Dec 31, 2020 | 10.98M | 3.25M | 41.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Adheris Health | 62.99M |
| Beamtree Holdings | 28.60M |
| Resonance Health | 11.07M |
| Visionflex Group | 4.65M |
| Vitasora Health | 3.71M |
| PainChek | 3.36M |
| HITIQ | 2.01M |
| Emyria | 1.39M |